Roche Organizational Structure & Org Chart
Roche's public structure is best understood through Pharmaceuticals, Diagnostics, Group research capability. The interactive chart is a researched, editable map of those published areas.
Roche organizational chart
Edit this organizational chart
Roche's reporting structure as of 2026-09. Drag to pan, scroll to zoom — or open it in QueryChart and edit it as your own.
- Industry
- Pharmaceuticals and diagnostics
- Headquarters
- Basel, Switzerland
- Founded
- 1896
- CEO
- Thomas Schinecker
- Ownership
- Public
- Structure as of
- 2026-09
- Structure last reviewed
- 2026-09-29
About the company
Roche is a pharmaceuticals and diagnostics organization. Its current public materials identify Pharmaceuticals, Diagnostics, Group research capability as useful ways to understand its activities. Roche has two operating divisions, Pharmaceuticals and Diagnostics. The chart shows group R&D as a shared capability, explicitly not a third reportable business division.
This QueryChart tree puts those disclosed areas next to a single, separately marked leadership branch for Thomas Schinecker. The business branches describe a public portfolio, not a confidential employee hierarchy. A line between a category and an offering means the offering belongs in that published category; it does not say that a particular executive personally manages every team shown.
Published businesses and operating areas
Pharmaceuticals is one of the visible areas in Roche's published structure. The division researches, develops and commercializes prescription medicines. The editable chart places Medicine portfolio and Pharma development beneath this branch so a reader can find concrete activities instead of a generic departmental box. This is a simplified grouping of disclosed work, and the sources below should be used for the exact legal entities, segment definitions and current management roles.
Diagnostics is one of the visible areas in Roche's published structure. Diagnostics develops tests, instruments and related digital solutions for clinical laboratories and care settings. The editable chart places Laboratory diagnostics and Diagnostic platforms beneath this branch so a reader can find concrete activities instead of a generic departmental box. This is a simplified grouping of disclosed work, and the sources below should be used for the exact legal entities, segment definitions and current management roles.
Group research capability is one of the visible areas in Roche's published structure. Research and development link drug and diagnostic expertise across the two divisions. The editable chart places Pharma research and Diagnostic innovation beneath this branch so a reader can find concrete activities instead of a generic departmental box. This is a simplified grouping of disclosed work, and the sources below should be used for the exact legal entities, segment definitions and current management roles.
Key leadership roles
Thomas Schinecker
Chief executive officer
How this structure supports the business
The Pharmaceuticals and Diagnostics branches answer different questions about Roche. The division researches, develops and commercializes prescription medicines. Diagnostics develops tests, instruments and related digital solutions for clinical laboratories and care settings. Showing them side by side is more informative than drawing an unsupported chain of managers, particularly when the public materials report a portfolio or service line rather than a complete internal org chart.
Roche has two operating divisions, Pharmaceuticals and Diagnostics. The chart shows group R&D as a shared capability, explicitly not a third reportable business division. Research and development link drug and diagnostic expertise across the two divisions. The diagram makes that distinguishing feature visible while keeping the named leadership layer separate. It is useful as a starting point for an editable company chart; users can replace the public groupings with their own teams, roles and verified reporting relationships.
Advantages and disadvantages
- The Pharmaceuticals branch uses a publicly described company-specific grouping.
- A portfolio branch does not prove an individual reporting line.
- The chart distinguishes Diagnostics from Group research capability.
- A single-parent tree cannot show every cross-business collaboration or legal-entity link.
Interesting facts
- Roche's public materials identify Pharmaceuticals as a major area.
- Diagnostics includes Laboratory diagnostics and Diagnostic platforms in this educational map.
- Group research capability is shown separately because research and development link drug and diagnostic expertise across the two divisions.
- The principal leadership role is identified as Thomas Schinecker.
Related process templates
Related organization charts
Frequently asked questions
How is Roche organized?
This educational chart maps Pharmaceuticals, Diagnostics, Group research capability, using the company's public materials. It does not attempt to reproduce a full internal employee hierarchy.
Who leads Roche?
Thomas Schinecker is the publicly identified chief executive officer in the sources reviewed on 29 September 2026.
Is this an official Roche org chart?
No. It is an independent reconstruction of public business categories and leadership information, with simplified connections for exploration and editing.
Use this org chart template
Open this Roche structure in QueryChart and rename roles, add departments, remove areas or change connections for your own organization.
